Apremilast May Offer Cardiometabolic Benefit in Psoriasis Patients
TUESDAY, Oct. 4, 2022 (HealthDay News) — For patients with moderate-to-severe psoriasis,...
Read More
Pharmacy
Infections Reported After Single Dose of Monkeypox Vaccine
TUESDAY, Oct. 4, 2022 (HealthDay News) — Most cases of monkeypox that occur after...
Read More
Topical Antibiotics Shorten Duration of Conjunctival Symptoms
TUESDAY, Oct. 4, 2022 (HealthDay News) — For children with acute infective conjunctivitis,...
Read More
Antidepressants in Pregnancy Do Not Affect Child Neurodevelopment
TUESDAY, Oct. 4, 2022 (HealthDay News) — Antidepressant use in pregnancy is not associated...
Read More
Vaccine-Associated Aluminum Linked to Persistent Asthma in Young Children
FRIDAY, Sept. 30, 2022 (HealthDay News) — There is an association between vaccine-associated...
Read More
FDA Approves Dupixent for Prurigo Nodularis
FRIDAY, Sept. 30, 2022 (HealthDay News) — The U.S. Food and Drug Administration approved...
Read More
Rubella Elimination Likely to Be Achievable in All Countries
FRIDAY, Sept. 30, 2022 (HealthDay News) — Rubella elimination is likely to be achievable in...
Read More
Early U.S. Data Show Jynneos Vaccine Protects Against Monkeypox
THURSDAY, Sept. 29, 2022 (HealthDay News) — The Jynneos vaccine, originally designed to...
Read More
Medicare Monthly Premiums to Drop for Seniors
WEDNESDAY, Sept. 28, 2022 (HealthDay News) — Millions of seniors who had to pay high...
Read More
New Drug for Alzheimer Disease Shows Promise in Phase 3 Trial
WEDNESDAY, Sept. 28, 2022 (HealthDay) — Japanese drugmaker Eisai on Wednesday said its...
Read More
Triplet Therapy Ups Progression-Free Survival in Advanced Kidney Cancer
MONDAY, Sept. 26, 2022 (HealthDay News) — Triplet therapy of cabozantinib + nivolumab +...
Read More
Semaglutide Reduces 10-Year Risk for T2D in Obese Persons
TUESDAY, Sept. 27, 2022 (HealthDay News) — Semaglutide reduces the 10-year risk for type 2...
Read More
Apixaban Noninferior to Enoxaparin for Postoperative VTE Prophylaxis
TUESDAY, Sept. 27, 2022 (HealthDay News) — Apixaban is noninferior to enoxaparin for...
Read More
Bivalent mRNA-1273.214 Elicits Better Response Against Omicron
TUESDAY, Sept. 27, 2022 (HealthDay News) — Interim results of an ongoing study show that use...
Read More
Treatment Benefits Adults With Major Depression, With or Without Childhood Trauma
TUESDAY, Sept. 27, 2022 (HealthDay News) — Adults with major depressive disorder and a...
Read More
Continuation of Anti-TNF for IBD After 24 Weeks of Pregnancy Beneficial
MONDAY, Sept. 26, 2022 (HealthDay News) — For women with inflammatory bowel disease (IBD),...
Read More
Multidose Antibiotic Prophylaxis No Better for Breast Implant Surgery
FRIDAY, Sept. 23, 2022 (HealthDay News) — Multiple-dose antibiotic prophylaxis is not...
Read More
Outcomes May Be Better for Warfarin Users Who Stop Aspirin Use
FRIDAY, Sept. 23, 2022 (HealthDay News) — Cutting aspirin use among patients treated with...
Read More
Neoadjuvant Novel Hormonal Agents Studied in High-Risk Prostate Cancer
THURSDAY, Sept. 22, 2022 (HealthDay News) — Neoadjuvant therapy with a novel hormonal agent...
Read More
Response to Neoadjuvant Endocrine Therapy for Breast Cancer May Vary by Race
TUESDAY, Sept. 20, 2022 (HealthDay News) — The response to neoadjuvant endocrine therapy...
Read More